Hosted on MSN23h
Moderna (MRNA) Reports Q4 Loss, Tops Revenue Estimates
Moderna (MRNA) came out with a quarterly loss of $2.50 per share versus the Zacks Consensus Estimate of a loss of $2.69. This compares to earnings of $0.55 per share a year ago. These figures are ...
Too Old to Operate3d
Genetic Susceptibility and Comorbidities in Psoriasis and HS
The following is a summary of “Patients with PSOriasis and Suppurative Hidradenitis (PSO-SH) share genetic risk factors and are at risk of increased morbidity.,” published in the February 2025 issue ...